Home Publications Research Data Research Grants Equipment Inventions & Patents Awards Additional Research Activities Faculties & Institutions Research Areas

Reply to: “Chemoradiotherapy in Pancreatic Cancer: Toward Precision Oncology, ” “Key Methodological Considerations in the Interpretation of the CONKO-007 Trial, ” and “Chemoradiotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer”

Fietkau R (2026)

---

Publication Type: Journal article

Publication year: 2026

Journal

Article Number: JCO-25-02926

DOI: 10.1200/JCO-25-02926

Authors with CRIS profile

How to cite

APA:

Fietkau, R. (2026). Reply to: “Chemoradiotherapy in Pancreatic Cancer: Toward Precision Oncology, ” “Key Methodological Considerations in the Interpretation of the CONKO-007 Trial, ” and “Chemoradiotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer”. Journal of Clinical Oncology. https://doi.org/10.1200/JCO-25-02926

MLA:

Fietkau, Rainer. "Reply to: “Chemoradiotherapy in Pancreatic Cancer: Toward Precision Oncology, ” “Key Methodological Considerations in the Interpretation of the CONKO-007 Trial, ” and “Chemoradiotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer”." Journal of Clinical Oncology (2026).

BibTeX: Download